Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001178913-25-004151
Filing Date
2025-12-31
Accepted
2025-12-31 13:13:15
Documents
2
Period of Report
2025-02-09

Document Format Files

Seq Description Document Type Size
1 zk2534153.html 4  
1 zk2534153.xml 4 7609
2 EXHIBIT 24.1 exhibit_24-1.htm EX-24.1 7301
  Complete submission text file 0001178913-25-004151.txt   16388
Mailing Address 12 ABBA HILLEL ROAD RAMAT GAN L3 5250606
Business Address 12 ABBA HILLEL ROAD RAMAT GAN L3 5250606 972-8-6286005
Silexion Therapeutics Corp (Issuer) CIK: 0002022416 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 13 ZAMENHOF STREET HERZLIYA L3 4659213
Business Address
Abramov Dror Yosef (Reporting) CIK: 0002034083 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42253 | Film No.: 251616782